Entero Therapeutics, Stock Price on October 16, 2024
| ENTO Stock | 0.42 0.02 5.00% |
Below is the normalized historical share price chart for Entero Therapeutics, extending back to October 11, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Entero Therapeutics, stands at 0.42, as last reported on the 22nd of November, with the highest price reaching 0.42 and the lowest price hitting 0.39 during the day.
If you're considering investing in Entero Stock, it is important to understand the factors that can impact its price. Entero Therapeutics, appears to be risky, given 3 months investment horizon. Entero Therapeutics, secures Sharpe Ratio (or Efficiency) of 0.0485, which denotes the company had a 0.0485% return per unit of risk over the last 3 months. By reviewing Entero Therapeutics,'s technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please utilize Entero Therapeutics,'s Downside Deviation of 8.73, coefficient of variation of 1257.98, and Mean Deviation of 7.52 to check if our risk estimates are consistent with your expectations.
At this time, Entero Therapeutics,'s Total Stockholder Equity is very stable compared to the past year. As of the 22nd of November 2024, Common Stock Shares Outstanding is likely to grow to about 353.2 K, while Other Stockholder Equity is likely to drop about 165.1 M. . As of the 22nd of November 2024, Price Earnings Ratio is likely to drop to -0.09. In addition to that, Price Book Value Ratio is likely to drop to 0.34. Entero Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 11th of October 2016 | 200 Day MA 3.1462 | 50 Day MA 0.5777 | Beta 1.373 |
Entero |
Sharpe Ratio = 0.0485
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ENTO | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.51 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.61 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Entero Therapeutics, is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entero Therapeutics, by adding it to a well-diversified portfolio.
Price Book 0.0684 | Book Value 7.991 | Enterprise Value 66.3 M | Enterprise Value Ebitda (0.10) | Shares Float 2.4 M |
Related Headline
Phio Pharmaceuticals Headline on 16th of October 2024
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound... by finance.yahoo.com
PH-894 Potent and Specific Silencing of BRD4 in NK CellsMarlborough, Massachusetts-- - Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company creating new pathways towards a cancer-free future by using its INTASYL siRNA gene silencing technology designed to make the bodys immune cells more effective in killing cancer cells. Phio announced today that it is presenting data about its INTASYL compound PH-894 at the American Society o
Entero Therapeutics, Valuation on October 16, 2024
It is possible to determine the worth of Entero Therapeutics, on a given historical date. On October 16, 2024 Entero was worth 0.47 at the beginning of the trading date compared to the closed value of 0.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Entero Therapeutics, stock. Still, in general, we apply an absolute valuation method to find Entero Therapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entero Therapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Entero Therapeutics,'s related companies.
| Open | High | Low | Close | Volume | |
| 0.48 | 0.49 | 0.45 | 0.45 | 121,600 | |
10/16/2024 | 0.47 | 0.64 | 0.45 | 0.56 | 1,188,218 |
| 0.54 | 0.73 | 0.54 | 0.73 | 1,240,700 |
| Backtest Entero Therapeutics, | | | Entero Therapeutics, History | | | Entero Therapeutics, Valuation | Previous | Next |
Entero Therapeutics, Trading Date Momentum on October 16, 2024
| On October 17 2024 Entero Therapeutics, was traded for 0.73 at the closing time. The top price for the day was 0.73 and the lowest listed price was 0.54 . The trading volume for the day was 1.2 M. The trading history from October 17, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 30.36% . The overall trading delta against the current closing price is 12.50% . |
Entero Therapeutics, Fundamentals Correlations and Trends
By evaluating Entero Therapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Entero Therapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Entero financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Entero Therapeutics, Stock history
Entero Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entero is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entero Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entero Therapeutics, stock prices may prove useful in developing a viable investing in Entero Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 336.3 K | 353.2 K |
Entero Therapeutics, Stock Technical Analysis
Entero Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Entero Therapeutics, Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Entero Therapeutics, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Entero Therapeutics, November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Entero Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entero Therapeutics, shares will generate the highest return on investment. By undertsting and applying Entero Therapeutics, stock market strength indicators, traders can identify Entero Therapeutics, entry and exit signals to maximize returns
Entero Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Entero Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Entero Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Entero to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0693 | |||
| Jensen Alpha | 0.7147 | |||
| Total Risk Alpha | (0.44) | |||
| Sortino Ratio | 0.106 | |||
| Treynor Ratio | 0.292 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entero Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics, guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entero Therapeutics,. If investors know Entero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entero Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.04) | Return On Assets (0.27) | Return On Equity (0.15) |
The market value of Entero Therapeutics, is measured differently than its book value, which is the value of Entero that is recorded on the company's balance sheet. Investors also form their own opinion of Entero Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Entero Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entero Therapeutics,'s market value can be influenced by many factors that don't directly affect Entero Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Entero Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Entero Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entero Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.